{"id":742689,"date":"2023-03-27T07:04:42","date_gmt":"2023-03-27T11:04:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/"},"modified":"2023-03-27T07:04:42","modified_gmt":"2023-03-27T11:04:42","slug":"passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/","title":{"rendered":"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PHILADELPHIA, March  27, 2023  (GLOBE NEWSWIRE) &#8212; <strong>Passage Bio, Inc.<\/strong> (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., chief executive officer, will participate in a fireside chat at the upcoming Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days on Monday, April 3, 2023 at\u00a03:55 p.m. ET in New York, NY.<\/p>\n<p>A live webcast of the event will be available on the Investors &amp; Media section of Passage Bio\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U-daqJrVBaqh_sXv12bFFhwyH0vDu4ffod3bg4M6ToGHG6L1Lbk5ObntZahfAOMqhcHrnwdMUmKuMcbWBWUAPIa4x2vxlUOHksmweyay_IE=\" rel=\"nofollow noopener\" target=\"_blank\">investors.passagebio.com<\/a>. A replay of the presentation will be available for 30 days following the event.<\/p>\n<p>\n        <strong>About Passage Bio <\/strong><br \/>\n        <br \/>Passage Bio (Nasdaq: PASG) is a clinical stage genetic medicines company on a mission to provide life-transforming therapies for patients with CNS diseases with limited or no approved treatment options. Our portfolio spans pediatric and adult CNS indications, and we are currently advancing clinical programs in GM1 gangliosidosis and frontotemporal dementia and our preclinical pipeline, including programs in amyotrophic lateral sclerosis and Huntington\u2019s disease. Based in Philadelphia, PA, our company has established a strategic collaboration and licensing agreement with the renowned University of Pennsylvania\u2019s Gene Therapy Program to conduct our discovery and IND-enabling preclinical work. Through this collaboration, we have enhanced access to a broad portfolio of gene therapy candidates and future gene therapy innovations that we then pair with our deep clinical, regulatory, manufacturing and commercial expertise to rapidly advance our robust pipeline of optimized gene therapies. As we work with speed and tenacity, we are always mindful of patients who may be able to benefit from our therapies. More information is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CSHR_IL15kqHm0MT9cbUFStu4dBzRaggGfTFhbUZSM-GRXmUx4kOxHGZ1AzQkuba1rjvyn-r6EIBBSmt6TPKMlLyTL1hkVij6Dh6q0TvdaE=\" rel=\"nofollow noopener\" target=\"_blank\">www.passagebio.com<\/a>.<\/p>\n<p>\n        <strong>For further information, please contact:<\/strong>\n      <\/p>\n<p>Passage Bio Investors:<br \/>Stuart Henderson<br \/>Passage Bio<br \/>267.866.0114<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=muMUxdBAyOlvM3qSifMFDl4t-dVIcYBTABMwnAtk4MkrF9PaRX5HoQXFnFBO2SbNIX4LrkvXAbT14oMu8wk-X8u78eSXdKYHmRZIaiSx3TY=\" rel=\"nofollow noopener\" target=\"_blank\">shenderson@passagebio.com<\/a><\/p>\n<p>Passage Bio Media:<br \/>Mike Beyer<br \/>Sam Brown Inc. Healthcare Communications<br \/>312.961.2502<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CjzWP9aqErI3krFPAL1ZqCAHHHBS_z8Fe5-xmbWvp3fd-GRbG4qADzAjzykiUb8WQU0qjMQPBhVW-nV0Cg4e_jjHUXy2YmEwBu6rGYgiQhKiWCP9E6FE8j08qVJqdngoDGayVe5hgRNrveGBIBXt6iVKe6OLmXORpwT7eQQ0f5saFouXXE42GfIkP8MeCtSNp0n5NOHOgUUiMNnJurnzDdAdowU57v47Ei4EiHIm_6XV1sbgsTsgwMMbzv_QbtTyW24ZokwrFD_yBDR_Zp0L8A==\" rel=\"nofollow noopener\" target=\"_blank\">MikeBeyer@sambrown.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YjNjZTQwNzUtMzdhNy00NmExLWE2MTEtZWE5MzdkYWQ4OWEyLTExNDgwMjg=\/tiny\/Passage-Bio.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, March 27, 2023 (GLOBE NEWSWIRE) &#8212; Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., chief executive officer, will participate in a fireside chat at the upcoming Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days on Monday, April 3, 2023 at\u00a03:55 p.m. ET in New York, NY. A live webcast of the event will be available on the Investors &amp; Media section of Passage Bio\u2019s website at investors.passagebio.com. A replay of the presentation will be available for 30 days following the event. About Passage Bio Passage Bio (Nasdaq: PASG) is a clinical stage genetic medicines company on a mission &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-742689","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, March 27, 2023 (GLOBE NEWSWIRE) &#8212; Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., chief executive officer, will participate in a fireside chat at the upcoming Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days on Monday, April 3, 2023 at\u00a03:55 p.m. ET in New York, NY. A live webcast of the event will be available on the Investors &amp; Media section of Passage Bio\u2019s website at investors.passagebio.com. A replay of the presentation will be available for 30 days following the event. About Passage Bio Passage Bio (Nasdaq: PASG) is a clinical stage genetic medicines company on a mission &hellip; Continue reading &quot;Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T11:04:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days\",\"datePublished\":\"2023-03-27T11:04:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/\"},\"wordCount\":316,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/\",\"name\":\"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=\",\"datePublished\":\"2023-03-27T11:04:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/","og_locale":"en_US","og_type":"article","og_title":"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Market Newsdesk","og_description":"PHILADELPHIA, March 27, 2023 (GLOBE NEWSWIRE) &#8212; Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., chief executive officer, will participate in a fireside chat at the upcoming Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days on Monday, April 3, 2023 at\u00a03:55 p.m. ET in New York, NY. A live webcast of the event will be available on the Investors &amp; Media section of Passage Bio\u2019s website at investors.passagebio.com. A replay of the presentation will be available for 30 days following the event. About Passage Bio Passage Bio (Nasdaq: PASG) is a clinical stage genetic medicines company on a mission &hellip; Continue reading \"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-27T11:04:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days","datePublished":"2023-03-27T11:04:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/"},"wordCount":316,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/","name":"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=","datePublished":"2023-03-27T11:04:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTIyMSM1NDc0OTI1IzIxMzY0NTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=742689"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742689\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=742689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=742689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=742689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}